<SEC-DOCUMENT>0001171520-22-000451.txt : 20220803
<SEC-HEADER>0001171520-22-000451.hdr.sgml : 20220803
<ACCEPTANCE-DATETIME>20220803161920
ACCESSION NUMBER:		0001171520-22-000451
CONFORMED SUBMISSION TYPE:	DFAN14A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20220803
DATE AS OF CHANGE:		20220803

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CATALYST BIOSCIENCES, INC.
		CENTRAL INDEX KEY:			0001124105
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				562020050
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DFAN14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-51173
		FILM NUMBER:		221132911

	BUSINESS ADDRESS:	
		STREET 1:		611 GATEWAY BLVD., SUITE 710
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		650-871-0761

	MAIL ADDRESS:	
		STREET 1:		611 GATEWAY BLVD., SUITE 710
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TARGACEPT INC
		DATE OF NAME CHANGE:	20000919

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SINGER JULIAN D.
		CENTRAL INDEX KEY:			0001628706

	FILING VALUES:
		FORM TYPE:		DFAN14A

	MAIL ADDRESS:	
		STREET 1:		2200 FLETCHER AVENUE
		STREET 2:		SUITE 501
		CITY:			FORT LEE
		STATE:			NJ
		ZIP:			07024
</SEC-HEADER>
<DOCUMENT>
<TYPE>DFAN14A
<SEQUENCE>1
<FILENAME>eps10404_jds.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 13.5pt Arial,sans-serif; margin: 0; text-align: center"><B>UNITED STATES </B></P>

<P STYLE="font: 13.5pt Arial,sans-serif; margin: 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>

<P STYLE="font: 12pt Arial,sans-serif; margin: 0; text-align: center"><B>Washington, DC 20549</B></P>

<P STYLE="font: 8pt Arial,sans-serif; margin: 0">&nbsp;</P>

<P STYLE="font: 16pt Arial,sans-serif; margin: 0; text-align: center"><B>SCHEDULE 14A </B></P>

<P STYLE="font: 6pt Arial,sans-serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 12pt Arial,sans-serif; margin: 0; text-align: center"><B>Proxy Statement Pursuant to Section 14(a) of the </B></P>

<P STYLE="font: 12pt Arial,sans-serif; margin: 0; text-align: center"><B>Securities Exchange Act of 1934</B></P>

<P STYLE="font: 12pt Arial,sans-serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman,serif; margin: 0 0 2pt"><FONT STYLE="font-family: Arial,sans-serif">Filed by the Registrant&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: MS Gothic">&#9744;</FONT></P>

<P STYLE="font: 12pt Times New Roman,serif; margin: 0 0 2pt"><FONT STYLE="font-family: Arial,sans-serif">Filed by a Party other than the
Registrant&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: MS Gothic">&#9745;</FONT></P>

<P STYLE="font: 12pt Arial,sans-serif; margin: 0 0 2pt">Check the appropriate box:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman,serif; margin-top: 0; margin-bottom: 2pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 27pt"><FONT STYLE="font-family: MS Gothic">&#9744;</FONT></TD><TD><FONT STYLE="font-family: Arial,sans-serif">Preliminary Proxy Statement </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman,serif; margin-top: 0; margin-bottom: 2pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 27pt"><FONT STYLE="font-family: MS Gothic">&#9744;</FONT></TD><TD><FONT STYLE="font-family: Arial,sans-serif">Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman,serif; margin-top: 0; margin-bottom: 2pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 27pt"><FONT STYLE="font-family: MS Gothic">&#9744;</FONT></TD><TD><FONT STYLE="font-family: Arial,sans-serif">Definitive Proxy Statement </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman,serif; margin-top: 0; margin-bottom: 2pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 27pt"><FONT STYLE="font-family: MS Gothic">&#9745;</FONT></TD><TD><FONT STYLE="font-family: Arial,sans-serif">Definitive Additional Materials </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman,serif; margin-top: 0; margin-bottom: 2pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 27pt"><FONT STYLE="font-family: MS Gothic">&#9744;</FONT></TD><TD><FONT STYLE="font-family: Arial,sans-serif">Soliciting Material Pursuant to &sect;240.14a-12</FONT></TD></TR></TABLE>

<P STYLE="font: 11pt Arial,sans-serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Arial,sans-serif; margin: 0; text-align: center"><FONT STYLE="font-size: 14pt"><B>CATALYST BIOSCIENCES, INC</B></FONT><B>.</B></P>

<P STYLE="font: 12pt Arial,sans-serif; margin: 0; text-align: center"><B>(Name of Registrant as Specified in Its Charter)</B></P>

<P STYLE="font: 12pt Arial,sans-serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 14pt Arial,sans-serif; margin: 0; text-align: center"><B>JDS1, LLC<BR>
CCUR HOLDINGS, INC.<BR>
CIDM II, LLC<BR>
JULIAN D. SINGER<BR>
DAVID S. OROS<BR>
SHELLY C. LOMBARD<BR>
MATTHEW STECKER<BR>
IGOR VOLSHTEYN</B></P>

<P STYLE="font: 12pt Arial,sans-serif; margin: 0; text-align: center"><B>(Name of Person(s) Filing Proxy Statement, if Other Than the
Registrant)</B></P>

<P STYLE="font: 10pt Arial,sans-serif; margin: 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 12pt Arial,sans-serif; margin: 0">Payment of Filing Fee (Check the appropriate box):</P>

<P STYLE="font: 12pt Arial,sans-serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; font: 12pt Times New Roman,serif"><FONT STYLE="font-family: MS Gothic">&#9745;</FONT></TD>
    <TD STYLE="width: 96%">
    <P STYLE="font: 12pt Arial,sans-serif; margin: 0; text-align: justify">No fee required</P>
    <P STYLE="font: 12pt Arial,sans-serif; margin: 0; text-align: justify">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 12pt Times New Roman,serif"><FONT STYLE="font-family: MS Gothic">&#9744;</FONT></TD>
    <TD>
    <P STYLE="font: 12pt Arial,sans-serif; margin: 0">Fee paid previously with preliminary materials</P>
    <P STYLE="font: 12pt Arial,sans-serif; margin: 0">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 12pt Times New Roman,serif"><FONT STYLE="font-family: MS Gothic">&#9744;</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman,serif"><FONT STYLE="font-family: Arial,sans-serif">Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 0-11</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 11pt Arial,sans-serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; padding-bottom: 2pt; border-bottom: rgb(98,145,178) 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 11pt Arial,sans-serif; margin: 0pt 0 12pt; text-align: justify">This Schedule 14A is being filed by JDS1, LLC, a Delaware
limited liability company (&ldquo;<U>JDS1</U>&rdquo;), CCUR Holdings, Inc., a Delaware corporation (&ldquo;<U>CCUR</U>&rdquo;), CIDM II,
LLC, a Delaware limited liability company (&ldquo;<U>CIDM II</U>&rdquo;), Julian D. Singer, David S. Oros, Shelly C. Lombard, Matthew
Stecker, and Igor Volshteyn (collectively, the &ldquo;<U>JDS1 Group</U>&rdquo;).</P>

<P STYLE="font: 11pt Arial,sans-serif; margin: 0pt 0 12pt; text-align: justify"><FONT STYLE="background-color: white"><B>Termination of Proxy
Contest at Catalyst Biosciences, Inc.</B></FONT></P>

<P STYLE="font: 11pt Arial,sans-serif; margin: 0pt 0 12pt; text-align: justify">On August 3, 2022, JDS1 withdrew its nominations of Shelly
C. Lombard, Matthew Stecker, and Igor Volshteyn for election to the Board of Directors (the &ldquo;<U>Board</U>&rdquo;) of Catalyst Biosciences,
Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), at the Company&rsquo;s 2022 Annual Meeting of Stockholders (the &ldquo;<U>Annual
Meeting</U>&rdquo;). JDS1 also withdrew its non-binding business proposal for consideration by stockholders at the Annual Meeting requesting
that the Board take action to declassify the Board.</P>

<P STYLE="font: 11pt Arial,sans-serif; margin: 0pt 0 12pt; text-align: justify">In connection with the withdrawal of its nominations and non-binding
business proposal, JDS1 and the other members of the JDS1 Group have terminated their solicitation of proxies to elect Ms. Lombard and
Messrs. Stecker and Volshteyn to the Board at the Annual Meeting.</P>

<P STYLE="font: 11pt Arial,sans-serif; margin: 0pt 0 12pt; text-align: justify">JDS1&rsquo;s withdrawal of its director nominations and non-binding
business proposal, and the JDS1 Group&rsquo;s termination of its solicitation of proxies at the Annual Meeting, is not pursuant to any
agreement, arrangement, or understanding with the Company or any other person. &#9;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
